跳至主要内容
临床试验/ACTRN12608000440325
ACTRN12608000440325已完成4 期

The immunological response of patients with anti-neutrophil cytoplasmic antibody (ANCA) vasculitis to the influenza vaccine compared to healthy individuals.

Royal Adelaide Hospital0 个研究点目标入组 100 人开始时间: 2008年9月3日最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients: Have biopsy-proven ANCA (Anti-neutrophil cytoplasmic antibodies) vasculitis and are currently in remission.
  • Healthy controls: Fit and well with no significant infection in the past month.

排除标准

  • Patients: Received an organ transplant, have end-stage renal failure, have a contraindication to receiving the influenza vaccine including egg allergy, pregnant
  • Controls: Diabetes, receiving any oral immunosuppressant therapy, Pregnancy, any significant end-organ disease.

研究者

相似试验

The response of vasculitis patients to influenza... | 临床试验